Available until July 31, 2025 - Online CNE/CME Course

This introductory module to the concepts of individualized medicine provides you with the knowledge needed to apply genomic concepts and testing methodologies into standard practice related to disease risk, diagnosis, and treatment.

Available until February 1, 2026

Testosterone has a variety of health benefits. It helps maintain bone density, muscle mass, red blood cell production and sexual function. Testosterone levels in men tend to peak between age 30 to 40 then gradually decline and it’s not unusual to find low testosterone levels in men over the age of 50. It’s also known that in men with hypogonadism, testosterone supplementation can improve libido, bone density and muscle mass. Should we be checking testosterone levels in our middle-age male patients? How do we determine who should receive testosterone supplementation and finally what are the risks of supplementation? In this podcast, these are all questions I’ll be asking our guest, Dr. Nahid Punjani, a urologist at the Mayo Clinic as we discuss “Testosterone Supplementation in Men”.

Available until September 15, 2024

This is an online course recommended for primary care providers. The course combines Mayo Clinic Talks podcast interviews about common musculoskeletal injuries and their clinical presentations with video demonstrations of joint exams as performed by Mayo Clinic orthopedic specialists.

Available until September 1, 2024 - Podcast Online CME Education

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes.

Available until February 1, 2026

The COVID-19 pandemic has caused innumerable health complications. One complication which hasn’t received a lot of attention has been the effect seen on mental health. Since the pandemic, the incidence of mental illness has increased dramatically, both in patients who have been infected as well as those suffering the social consequences of the pandemic. This has led to mental health disorders representing a major cause of disability. What can we learn from a historical perspective as a result of previous pandemics? How does the COVID-19 virus produce the variety of neuropsychiatric disorders commonly seen? And most importantly, how can we help our patients with their mental health disorders associated with the pandemic? This podcast will review “Psychiatric Issues Stemming From COVID-19” with our guest, Teresa A. Rummans, M.D., a psychiatrist from the Department of Psychiatry and Psychology at the Mayo Clinic.

Available until February 1, 2026

Summary: Flu and cold season is an annual concern for people around the world. Specifically in the United States, there are massive disparities in both care and outcomes for communities of color related to both diagnosis and treatment of flu and cold. On this episode of the RISE for Equity podcast, Dr. Nusheen Ameenuddin joins host Nicole Nfonoyim-Hara to discuss COVID’s impact on cold and flu, protecting our communities, and how we can improve education and access to care for marginalized communities. “The truth of the matter is genetically, we're all very similar. It's not an issue of race, it's an issue of racism. When we actually step back, people can be like, ‘Oh, that situation was a one-off.’ And when we actually look at the data, it's not a one-off. The fact is, we're not asking the right questions, and we need to look deeper to ensure that we are providing the best possible care, the most objective care, the most patient-centered care, particularly when we see that we're falling short. And, and the numbers don't lie.” - Dr. Nusheen Ameenuddin Guest: Dr. Nusheen Ameenuddin is currently an Assistant Professor and Consultant (tenured staff physician) in the Division of Community Pediatric and Adolescent Medicine, Department of Pediatrics, at the Mayo Clinic, Rochester, MN. Please visit the RISE for Equity website for more information.

Available until February 1, 2026

It’s estimated that between 2% and 3% of the population has some form of valvular heart disease and this increases with age. Most of these patients are initially cared for by primary care providers. Most valvular disease deaths are due to disease of the aortic valve and it’s important to recognize these patients early in order to assess for progression and the need for surgical intervention. What are the presenting symptoms of aortic valve disease? What’s the best way to manage and follow these patients and when should a cardiologist and cardiac surgeon become involved in the care of the patient? In this podcast, we’ll discuss these questions and more with cardiologist Rekha Mankad, M.D., from the Mayo Clinic.